Can this five-bagger continue to sparkle?

This stock could still deliver plenty of fizz, says Harvey Jones.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Last time I looked at AIM-listed tonic maker Fevertree Drinks (LSE: FVER) it was full of fizz. Its share price had risen almost 200% in a year and management was fired up about the future, issuing a bullish trading update anticipating a 77% rise in second half sales and 71% growth in revenues to £59.2m.

High spirits

As Shakespeare wrote in Julius Caesar, “there is a tide in the affairs of men, which taken at the flood, leads on to fortune”, and in this case it is the flood of craft distillers that are reviving gin’s tired reputation that has created the fortune.

We live in a golden age of gin, which is a far happier one than the bleak Hogarthian image. Instead of mother’s ruin, we now have hipster’s reward, as drinkers learn to distinguish Gordon’s from Sipsmith, and Beefeater from Hendrick’s.

Fever tree founders Tim Warrilow and ‘gin guru’ Charles Rolls have been surfing the tide, after realising that the gin renaissance had not been matched by an artisanal tonic water revival, with Schweppes pretty much the only mixer available for all those exciting new gin formulations.

Gin up!

Rather than packing their mixers with the usual fizzy drink chemicals, Warrilow and Rolls shunned artificial sweeteners and sourced pharmaceutical-grade quinine, giving their premium tonic water a cleaner taste and aroma. Investors who got in early have enjoyed the sweet smell of success, with the share price up around 500% in the last two years.

Everybody likes a five-bagger, especially one that goes nicely with ice and a slice. But the question is whether Fevertree Drinks can continue to sparkle. It will certainly need to, given its sky-high valuation of 91 times earnings. That’s forecast to drop to 50 times at the end of this year, thanks to continued rapid earnings per share (EPS) growth, projected to be 87% this year. However, that is down from 303% last year, so the momentum is slowing. For 2017 the forecast is for EPS growth of a much more sober 9%.

That’s the spirit

This year, earnings are forecast to rise 55%, from around £59m to £93m. Next year, they are forecast to hit £109m, a rise of ‘just’ 17%. There is a danger that this slowing pattern will continue, as the artisan gin revolution will run out of steam one day. Also, tonic water competition is a lot stiffer than it was, with Fentimans, 1724, Bramely & Gage’s 6 O’Clock, and Pellegrino all battling for drinkers’ attention. Tonic giant Schweppes, which is owned by Coca-Cola, is fighting back with its own range of premium mixers.

Fevertree still hits the right spot, with the share price almost doubling from 583p to 1,055p since I raised my glass to the stock on 19 February 2016 (when its valuation was stood at a whopping 203 times earnings). Management expects full-year results to beat market expectations after a spirited performance in the second half of this year. It still looks a tempting buy, although its five-bagging days are surely over.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

2 FTSE income stocks investors should consider buying in April

Income stocks are a great way to build wealth. Our writer details two picks she believes investors should consider snapping…

Read more »

Investing Articles

What might the 5-year price chart tell us about BT shares?

Christopher Ruane considers what clues the long-term performance of BT shares might offer him about business performance and whether to…

Read more »